Is a complete NSE/INDRAMEDCO research report available?

Question

Accepted Answer

No complete published report is available for nse/INDRAMEDCO (NSE/INDRAMEDCO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	33.2B
Revenue (ttm)	14.8B
Net income (ttm)	1.8B
EPS (ttm)	₹20.0
Shares out	91.7M
P/E (trailing)	18.1x
P/E (forward)	16.1x
Dividend	₹4.00 (1.08%)

Metric	Value
Country	India
Country code	IN
Employees	3,035
Employees Change	58%
Employees Change Percent	1.95
Enterprise value	INR 31B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	67.15
Industry PE Fwd	46.04
Isin	INE681B01017
Last refreshed	2026-07-30
Market cap	INR 33.2B
Price	INR 363
Price currency	INR
Rev Per Employee	4,884,711.7x
Sector	Healthcare
Sector PE	46.52
Sector PE Fwd	37.94
Sic	8062
Symbol	nse/INDRAMEDCO
Website	https://www.apollohospitals.com/delhi/

Metric	Value
Earnings Yield	5.52%
EV Earnings	16.87x
EV/EBIT	13.88x
EV/EBITDA	11.61x
EV/FCF	28.75x
EV/Sales	2.09x
FCF yield	3.24%
Forward P/E	16.07x
P/B ratio	4.49x
P/E ratio	18.11x
P/S ratio	2.24x
PE Ratio10 Y	22.02x
PE Ratio3 Y	19.76x
PE Ratio5 Y	16.13x

Metric	Value
EBIT Margin	15.06%
EBITDA Margin	18%
FCF margin	7.27%
Gross margin	37.04%
Gross Profit	INR 5.5B
Gross Profit Growth	-33.72%
Gross Profit Growth Q	-71.52%
Gross Profit Growth3 Y	-4.76%
Gross Profit Growth5 Y	13.81%
Net Income	INR 1.8B
Net Income Growth	14.06%
Net Income Growth Q	1.68%
Net Income Growth Quarters	22%
Net Income Growth Years	5%
Net Income Growth3 Y	28.69%
Net Income Growth5 Y	139.5%
Pretax Margin	16.59%
Profit Margin	12.39%
Profit Per Employee	INR 605,008
Profitable Quarters	INR 23
Profitable Years	21
ROA	15.14
Roa5y	14.37
ROCE	27.17
ROE	27.47
Roe5y	26.08
ROIC	44.91
Roic5y	37.66

Metric	Value
Cagr10y	23.52%
Cagr15y	19.26%
Cagr1y	-18.95%
Cagr20y	16.76%
Cagr3y	46.06%
Cagr5y	36.85%
Div CAGR10	9.6%
Div CAGR3	21.64%
Div CAGR5	22.98%
EPS Growth	14.07
EPS Growth Q	1.82
EPS Growth Quarters	16
EPS Growth Years	5
EPS Growth3 Y	28.69
EPS Growth5 Y	140.3
FCF Growth	-10.49%
FCF Growth3 Y	2.57%
FCF Growth5 Y	79.1%
OCF Growth	6.82%
OCF Growth10 Y	10.4%
OCF Growth3 Y	5.04%
OCF Growth5 Y	44.25%
Revenue Growth	9.3x
Revenue Growth Q	9.31x
Revenue Growth Quarters	21x
Revenue Growth Years	5x
Revenue Growth3 Y	10.5x
Revenue Growth5 Y	19.3x

NSE/INDRAMEDCO (NSE/INDRAMEDCO)

Coverage state: Market snapshot only — no published research

Generate the first NSE/INDRAMEDCO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/INDRAMEDCO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/INDRAMEDCO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/INDRAMEDCO

Frequently asked questions

Metric	Value
Asset Turnover	INR 1.61
Assets	INR 9.9B
Cash	INR 2.6B
Current Assets	INR 4.2B
Current Liabilities	INR 1.7B
Debt	INR 368.6M
Debt EBITDA	INR 0.14
Debt Equity	INR 0.05
Debt FCF	INR 0.34
Equity	INR 7.4B
Interest Coverage	37.09
Liabilities	INR 2.5B
Long Term Assets	INR 5.7B
Long Term Liabilities	INR 814.4M
Net Cash	INR 2.3B
Net Cash By Market Cap	INR 6.81
Net Cash Growth	-20.78%
Net Debt EBITDA	INR -0.85
Net Debt Equity	INR -0.31
Net Debt FCF	INR -2.1
Tangible Book Value	INR 7.4B
Tangible Book Value Per Share	INR 80.75
WACC	6.6

Metric	Value
Current ratio	2.46
Inventory Turnover	125.7
Net Working Capital	INR -125.8M
Quick ratio	2.27
Working Capital	INR 2.5B
Working Capital Turnover	INR 5.94

Metric	Value
Buyback Yield	0%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 4
Dividend Years	4
Dividend Yield	1.08%
Ex Div Date	2025-09-18
Last Dividend	INR 4.5
Payout Frequency	Annual
Payout Ratio	22.47%

Metric	Value
10Y total return	726.21%
1Y total return	-18.94%
200-day SMA	432.4
3Y total return	211.68%
50-day SMA	378.8
50-day SMA vs 200-day SMA	50under200
5Y total return	379.91%
All Time High	640.9
All Time High Change	-43.4%
All Time High Date	2025-11-06
All Time Low	5
All Time Low Change	7,154%
All Time Low Date	1998-10-15
ATR	9.38
Beta	0.42
Beta1y	0.56
Beta2y	0.47
Ch YTD	-19.06
High	371.8
High52	640.9
High52 Date	2025-11-06
High52ch	-43.4%
Low	361
Low52	342
Low52 Date	2026-01-27
Low52ch	6.05%
Ma50ch	-4.24%
Price vs 200-day SMA	-16.11%
RSI	37.91
RSI Monthly	48.66
RSI Weekly	40.83
Sharpe ratio	-0.49x
Sortino ratio	-0.62
Total Return	1.09%
Tr YTD	-19.06
Tr15y	1,303.59%
Tr1m	-5.9%
Tr1w	-3.1%
Tr3m	-9.61%

Metric	Value
Operating Income	INR 2.2B
Operating Income Growth	11.39
Operating Income Growth Q	-3.46
Operating Income Growth3 Y	25.75
Operating Income Growth5 Y	96.3
Operating margin	15.06

Metric	Value
Float	40,945,299%
Net Borrowing	-24,300,000
Shares Insiders	2.9%
Shares Institutions	5.08%
Shares Out	91,673,000
Shares Qo Q	-0.08%
Shares Yo Y	-0%

Metric	Value
Average Volume	120,778.1x
Bv Per Share	80.78
CAPEX	INR -596.5M
Ch10y	568.6
Ch15y	826.4
Ch1m	-5.9
Ch1w	-3.1
Ch1y	-19.69
Ch20y	1,150.7
Ch3m	-9.61
Ch3y	200.1
Ch5y	346.4
Ch6m	-0.9
Change	-1.79%
Change From Open	-2.04
Close	369.3
Days Gap	0.26
Depreciation Amortization	436,300,000
Dollar Volume	162,443,899.8
Earnings Date	2026-08-06
EBIT	INR 2.2B
EBITDA	INR 2.7B
EPS	INR 20.03
F Score	4
FCF	INR 1.1B
FCF EV Yield	3.48x
FCF Per Share	INR 11.76
Financing CF	-463,800,000
Fiscal Year End	March
Founded	1,983
Graham Number	190.80678
Graham Upside	-47.39
Income Tax	INR 624M
Investing CF	-1,776,100,000
Is Primary Listing	1
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Lynch Fair Value	INR 501
Lynch Upside	38.06
Ma150	398.1
Ma150ch	-8.9%
Ma20	374.6
Ma20ch	-3.18%
Net CF	-565,500,000
Next Earnings Date	2026-08-06
Open	370.3
P FCF Ratio	30.85
P OCF Ratio	19.86
Payment Date	2025-10-24
Position In Range	16.2
Ppne	3,672,700,000
Price Date	2026-07-29
Price EBITDA	INR 12.46
Ptbv Ratio	4.49
Relative Volume	4.31x
Revenue	14,825,100,000x
Tax By Revenue	4.21x
Tax Rate	25.36%
Tr20y	2,118.39%
Tr6m	-0.9%
Volume	447,874